Skip to content
Review Open access

Evaluation of Drug-Related Problems and Pharmacist Interventions in Hospitalized Patients: A Prospective Observational Study

Oct 2026 · PAIN, JOINTS, SPINE · 0 citations · 23 references

TL;DR

Elderly inpatients with polypharmacy and cardiovascular comorbidities represent the highest risk group for preventable DRPs, and proactive clinical pharmacist integration through daily ward rounds and medication reconciliation achieves a high rate of problem resolution, enhancing inpatient drug safety.

Abstract

Background: Drug-related problems (DRPs) pose critical challenges in acute inpatient care, significantly undermining therapeutic efficacy, increasing patient safety hazards, and escalating healthcare expenditures.Objective: To evaluate the incidence, nature, underlying causes, and clinical outcomes of DRPs in hospitalized inpatients, alongside assessing the impact of clinical pharmacist-led interventions in a tertiary care setting. Setting: Inpatient Department (IPD) of Shivapuje Heart Care Hospital, Latur, Maharashtra, India over a 6-month prospective study period (2024–2025). Method: A prospective observational study enrolled 100 adult hospitalized inpatients (length of stay ≥24 hours) using consecutive sampling. Daily medication chart reviews, laboratory tracking, and direct clinical monitoring were conducted. Identified DRPs were systematically categorized according to the Pharmaceutical Care Network Europe (PCNE V9.1) classification framework. Interventions were offered at prescriber and drug levels, and clinical resolution was tracked until discharge. Main outcome measure: Incidence and nature of DRPs (PCNE V9.1 Problem, Cause, Intervention, and Outcome domains), proportion of manifest vs. potential problems, high-risk drug classes, and overall pharmacist-mediated clinical resolution rate (Outcome c + d). Results: Among 100 enrolled inpatients (53% male; peak age 69–81 years at 28%), hypertension (58%) and diabetes mellitus (52%) were the primary comorbidities. Overall, 57% of identified DRPs were manifest problems (actual clinical harm), while 43% were potential problems. Under PCNE V9.1 domains, Adverse Drug Reactions (P2) comprised 72.7% of categorized issues, dominated by non-allergic events (51.51%). Etiological assessment of 154 cause codes identified Dose Selection errors (C3) as the primary cause, where excessive dosing (C3.b) represented 80.5% of dose errors. Inappropriate drug selection (C1.a) and combination (C1.b) accounted for 22.07% and 18.18% of causes, respectively. High-risk drug classes implicated included antiplatelets/anticoagulants (20%), antibiotics (19%), and diuretics (12%). Clinical pharmacist interventions led to drug cessation in 76.38% of drug-level actions and therapy modifications in 24.08% of prescriber actions. Overall, 38% of DRPs were completely resolved and 36% were partially resolved, achieving a 74% positive clinical resolution rate. Conclusion: Elderly inpatients with polypharmacy and cardiovascular comorbidities represent the highest risk group for preventable DRPs. Proactive clinical pharmacist integration through daily ward rounds and medication reconciliation achieves a high rate of problem resolution, enhancing inpatient drug safety.  

Read PDF

Similar papers

Review Open access Oct 2026

Drug-Related Problems and Clinical Pharmacist Interventions in Intensive Care Unit Patients: A Cross-Sectional Study

Background: Drug-related problems (DRPs) are highly prevalent among critically ill patients in intensive care units (ICUs) and may negatively influence clinical outcomes. Pharmacist-led interventions play a pivotal role in detecting and resolving DRPs; however, their implementation and acceptance vary across healthcare...

Sarah Mousavi, M. Karimi, S. Farsaei · 0 citations
Review Open access Sep 2026

Impact of Medication-Related Problems in Hospitalized Patients Eligible for Palliative Care: A Prospective Cohort Study.

BACKGROUND Hospitalized patients receiving palliative care frequently present multimorbidity and polypharmacy, increasing exposure to adverse drug events (ADEs). Evidence specific to this population, particularly in middle-income countries, remains scarce. METHODS Prospective observational cohort study conducted from...

Jéssica Gonçalves Rangel, M. F. Ribeiro, A. Maure et al. · 0 citations
Review Open access Oct 2026

EVALUATION OF CLINICAL PHARMACY INTERVENTIONS AND MEDICATION-RELATED PROBLEMS AT PRINCESS HAYA BINT AL-HUSSEIN MILITARY HOSPITAL: A RETROSPECTIVE OBSERVATIONAL STUDY

Background: In the hospital setting, clinical pharmacy services are an integral part of optimizing medication therapy, improving patient safety, and reducing healthcare costs. Pharmacists’ interventions in identification and resolution of drug-related problems (DRPs) are crucial for improving patient outcomes and reduc...

Rana Faisal Al Qudah, Al-Anoud Jaafar Al-Haniti, Rola Raed Farhan Alsamrdali et al. · 0 citations
Review Open access Oct 2026

Impact of Pharmacist-Led Polypharmacy Management on Prescribing Patterns in Older Inpatients: A Real-World Study in a Chronic Care Hospital.

It is suggested that pharmacist-led interventions in chronic care settings may contribute to reducing medication burden and modifying prescribing patterns beyond simple medication count reduction.

Takefumi Miyake, Yu Nakamura, Kana Masui et al. · 0 citations
Open access Oct 2026

Evaluation of Therapeutic Outcome in Hospitalised Patients – Clinical Pharmacist’s Perspective

Assessment of therapeutic outcomes in hospitalized patients is important for ensuring effective treatment and supporting clinical decision-making. Main objective of the study was to evaluate therapeutic outcomes in hospitalized patients using laboratory and vital parameters, assess drug effectiveness, and identify fact...

Binu Km, H. Doddayya, Channabasaiah Hm et al. · 0 citations
Review Open access Nov 2026

Drug-related problems among hospitalized patients with cardiovascular diseases in China: a retrospective study

Data are lacking on the baseline characteristics of drug-related problems (DRPs) and the impact of clinical pharmacy activities among patients with cardiovascular diseases (CVDs) in China. This study aimed to characterize the features of DRPs in patients with CVDs and to identify factors associated with the presenc...

Xi-Nan Wu, De-Ying Xu, Qian Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.